Showing results (11-20 of 20) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 20 results.
Cell Reports|August 8, 2023
CdGAP is a talin-binding protein and a target of TGF-β signaling that promotes HER2-positive breast cancer growth and metastasisYi He, Marie-Anne Goyette, Jennifer Chapelle, et al.
Communications Biology|September 8, 2021
CdGAP promotes prostate cancer metastasis by regulating epithelial-to-mesenchymal transition, cell cycle progression, and apoptosisChahat Mehra, Ji-Hyun Chung, Yi He, et al.
The American Journal of Clinical Nutrition|July 5, 2025
Biological responses during high-dose protein nutrition in the critically ill: a randomized controlled trialArnold S Kristof, Mengyin Hong, Nadia Boufaied, et al.
Research Square|September 2, 2025
EZH2-TTP-mTORC1 Axis Drives Phenotypic Plasticity and Therapeutic Vulnerability in Lethal Prostate CancerLeigh Ellis, Beatriz German, Katherine Morel, et al.
Nature Communications|April 23, 2024
The gut microbiome-prostate cancer crosstalk is modulated by dietary polyunsaturated long-chain fatty acidsGabriel Lachance, Karine Robitaille, Jalal Laaraj, et al.
JCI Insight|May 23, 2022
Response to supraphysiological testosterone is predicted by a distinct androgen receptor cistromeXintao Qiu, Lisha G Brown, Jennifer L Conner, et al.
Biorxiv : the Preprint Server for Biology|August 20, 2025
EZH2-TTP-mTORC1 Axis Drives Phenotypic Plasticity and Therapeutic Vulnerability in Lethal Prostate CancerBeatriz German, Katherine L Morel, Teia Noel, et al.
Cancer Research|June 4, 2024
Obesogenic High-Fat Diet and MYC Cooperate to Promote Lactate Accumulation and Tumor Microenvironment Remodeling in Prostate CancerNadia Boufaied, Paolo Chetta, Tarek Hallal, et al.
Nature Communications|May 13, 2022
MYC drives aggressive prostate cancer by disrupting transcriptional pause release at androgen receptor targetsXintao Qiu, Nadia Boufaied, Tarek Hallal, et al.
Nature Cancer|April 26, 2021
EZH2 inhibition activates a dsRNA-STING-interferon stress axis that potentiates response to PD-1 checkpoint blockade in prostate cancerKatherine L Morel, Anjali V Sheahan, Deborah L Burkhart, et al.
Pageof 2